Evidence map›Paper›PMID 26682942›Full record

ArticleJournal of hypertension2016

Hu antigen R is required for NOX-1 but not NOX-4 regulation by inflammatory stimuli in vascular smooth muscle cells.

Andrea Aguado, Thierry Fischer, Cristina Rodríguez, Adrian Manea, José Martínez-González, Rhian M Touyz, Raquel Hernanz, M Jesús Alonso, Dan A Dixon, Ana M Briones and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of hypertension, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Andrea AguadoaDepartment Farmacología, Universidad Autónoma de Madrid, Instituto de Investigación Hospital La Paz (IdiPAZ)bDepartment Immunology and Oncology, Centro Nacional de Biotecnología (CNB/CSIC), MadridcCentro de Investigación Cardiovascular (CSIC-ICCC), IIB-Sant Pau, Barcelona, SpaindDepartment Genomics, Transcriptomics and Molecular Therapies, Institute of Cellular Biology and Pathology 'Nicolae Simionescu', Bucharest, RomaniaeInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UKfDepartment Ciencias Básicas de la Salud, Universidad Rey Juan Carlos, Alcorcón, SpaingDepartment Cancer Biology, University of Kansas Medical Center, Kansas City, USA*Ana M. Briones and Mercedes Salaices contributed equally to this article.
Thierry Fischer
Cristina Rodríguez
Adrian Manea
José Martínez-González
Rhian M Touyz
Raquel Hernanz
M Jesús Alonso
Dan A Dixon
Ana M Briones
Mercedes Salaices
Universidad Autónoma de Madrid · ESUniversidad Rey Juan Carlos · ESCentro Nacional de Biotecnología · ESThe University of Kansas Cancer Center · USUniversity of Glasgow · GB

Funding

Post-Transcriptional Regulation in Colorectal CancerR01CA134609 · NCI · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI DIXON, DAN ALAN · 2009 to 2013
$1.4M
British Heart Foundation RG/13/7/30099CIHRNCI NIH HHS R01 CA134609NCI NIH HHS R01CA134609
6 · The paper itself

Abstract

objectiveNOX-1 and NOX-4 are key enzymes responsible for reactive oxygen species (ROS) generation in vascular smooth muscle cells (VSMC). The RNA-binding protein Hu antigen R (HuR) is implicated in posttranscriptional regulation of gene expression; however, its role regulating NOX is unknown. We investigated transcriptional and posttranscriptional mechanisms underlying angiotensin II (AngII) and IL-1β regulation of NOX-1 and NOX-4 in VSMC and their implications in cell migration.

methodsRat and human VSMC were stimulated with AngII (0.1 μmol/l) and/or IL-1β (10 ng/ml). NOX-1 and NOX-4 mRNA and protein levels, NOX-1 and NOX-4 promoter and 3'UTR activities, NADPH oxidase activity, ROS production, and cell migration were studied.

resultsIL-1β increased NOX-1 expression, NADPH oxidase activity and ROS production, and decreased NOX-4 expression and H2O2 production in VSMC. AngII potentiated the IL-1β-mediated induction of NOX-1 expression, NADPH oxidase activity, ROS production, and cell migration. However, AngII did not influence IL-1β-induced NOX-4 downregulation. AngII + IL-1β interfered with the decay of NOX-1 mRNA and promoted HuR binding to NOX-1 mRNA. Moreover, HuR blockade reduced NOX-1 mRNA stability and AngII + IL-1β-induced NOX-1 mRNA levels. IL-1β decreased NOX-4 expression through a transcriptional mechanism that involved response elements situated in the proximal promoter. AngII and/or IL-1β-induced cell migration were prevented by NOX-1 and HuR blockade and were augmented by NOX-4 overexpression.

conclusionIn VSMC HuR-mediated mRNA stabilization is partially responsible for AngII + IL-1β-dependent NOX-1 expression, whereas transcriptional mechanisms are involved in decreased NOX-4 expression induced by IL-1β. NOX4 and HuR regulation of NOX-1 contributes to VSMC migration, important in vascular inflammation and remodeling.

Indexed as

Angiotensin IIAnimalsCell MovementCells, CulturedELAV-Like Protein 1Gene Expression RegulationHumansHydrogen PeroxideInterleukin-1betaMuscle, Smooth, VascularMyocytes, Smooth MuscleNADH, NADPH OxidoreductasesNADPH Oxidase 1NADPH Oxidase 4NADPH OxidasesRatsAngiotensin IIELAV-Like Protein 1Hydrogen PeroxideInterleukin-1betaNADH, NADPH OxidoreductasesNADPH Oxidase 1NADPH Oxidase 4NADPH OxidasesNOX1 protein, humanNOX4 protein, humanNox4 protein, ratReactive Oxygen SpeciesRNA, Messenger

Identifiers

PMID26682942
PMCPMC4947528
OpenAlexW2312058115

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.